cancer

A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins
A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins
Stat
Arrakis Therapeutics
RNA
cancer
Flag link:
First U.S. Patients Treated With CRISPR As Gene-Editing Human Trials Get Underway
First U.S. Patients Treated With CRISPR As Gene-Editing Human Trials Get Underway
NPR
CRISPR
cancer
gene editing
Flag link:
5 things to know about Hookipa Pharma ahead of its IPO
5 things to know about Hookipa Pharma ahead of its IPO
Marketwatch
Hookipa
IPOs
cancer
infectious diseases
Flag link:
Hookipa proposes IPO as its cancer vaccines head towards the clinic
Hookipa proposes IPO as its cancer vaccines head towards the clinic
BioCentury
Hookipa
IPOs
vaccines
cancer
infectious diseases
Flag link:
Enterome to Collaborate with Dana-Farber Cancer Institute on Microbiome Immunotherapies
Enterome to Collaborate with Dana-Farber Cancer Institute on Microbiome Immunotherapies
CP WIre
Enterome
cancer
cancer immunotherapies
Flag link:
An AIDS therapy involving parasite injections was discredited. China is reviving it — for cancer
An AIDS therapy involving parasite injections was discredited. China is reviving it — for cancer
Stat
Henry Heimlich
China
malarial therapy
cancer
Flag link:
FDA looks to broaden cancer trial eligibility
FDA looks to broaden cancer trial eligibility
BioCentury
FDA
cancer
clinical trials
oncology
Flag link:
Hospitals are saving lives with CAR-T. Getting paid is another story
Hospitals are saving lives with CAR-T. Getting paid is another story
Stat
CAR-T
drug pricing
cancer
hospitals
Flag link:
Page.AI Nabs FDA Breakthrough Device Designation for First AI-driven Cancer Diagnosis
Page.AI Nabs FDA Breakthrough Device Designation for First AI-driven Cancer Diagnosis
RAPS.org
Paige.AI
artificial intelligence
FDA
breakthrough therapy
devices
cancer
diagnostics
Flag link:
FDA Urges Caution in Use of Robotic Surgical Devices for Cancer-Related Procedures
FDA Urges Caution in Use of Robotic Surgical Devices for Cancer-Related Procedures
RAPS.org
robotic surgery
FDA
cancer
Flag link:
Using Bristol-Myers’ popular leukemia drug to improve anti-PD-1 cancer immunotherapy
Using Bristol-Myers’ popular leukemia drug to improve anti-PD-1 cancer immunotherapy
Fierce Biotech
cancer
Cedars Sinai
Bristol-Myers Squibb
Sprycel
anti-PD-L1
Flag link:
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
Yahoo/Reuters
Bayer
Vitrakvi
cancer
Eli Lilly
Loxo Oncology
Flag link:
HaiHe raises $147M to advance cancer candidates
HaiHe raises $147M to advance cancer candidates
BioCentury
Shanghai HaiHe Biopharma
China
cancer
Flag link:
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
BioSpace
Sanofi
Rare Diseases
immunology
cancer
R&D
Flag link:
HiberCell Launches With $60 Million on Mission to Prevent Cancer Relapse and Metastasis
HiberCell Launches With $60 Million on Mission to Prevent Cancer Relapse and Metastasis
CP Wire
HiberCell
cancer
metastatic cancer
Flag link:
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
The bispecific boom: Genentech pays $120M to tie the knot with Xencor on an IL-15 alliance
Endpoints
Genentech
Xencor
IL-15
XmAb24306
cancer
bispecific antibodies
Flag link:
Can Digital Medicine Improve Drug Adherence?
Can Digital Medicine Improve Drug Adherence?
Forbes
cancer
digital health
patient adherence
Proteus Digital Health
Flag link:
Israeli Scientists Say They Will Have A Complete Cure For Cancer Within A Year
Israeli Scientists Say They Will Have A Complete Cure For Cancer Within A Year
Forbes
cancer
Israel
bacteriophage
Accelerated Evolution Biotechnologies
MuTaTo
Flag link:
Pfizer’s Cancer Portfolio Expected to Rake in $8.3 Billion in 2019
Pfizer’s Cancer Portfolio Expected to Rake in $8.3 Billion in 2019
BioSpace
Pfizer
oncology
cancer
Flag link:
A two-fisted punch against cancer metastasis
A two-fisted punch against cancer metastasis
Fierce Biotech
cancer
MMP inhibitors
Duke University
oncology
Flag link:

Pages